Urobo Biotech

Cover Block

Company Name	Urobo Biotech
Tagline	Enzymatic conversion of bioplastic waste to chemicals and fuels in mixed streams
Headquarters	Stellenbosch, South Africa
Founded	2023
Stage	Pre-Seed
Business Model	B2B
Industry	Cleantech / Climatetech
Technology	Biotech / Life Sciences
Geography	Sub-Saharan Africa
Growth Profile	Venture Scale
Founding Team	Academic Spinout
Funding Label	Undisclosed

Links

• Website: https://www.urobobiotech.com
• LinkedIn: https://za.linkedin.com/company/urobo-biotech

Executive Summary

Urobo Biotech is an early-stage biotech spinout from Stellenbosch University developing enzymatic processes to convert bioplastic waste into chemicals and fuels [urobobiotech.com]. Founded in 2023 by a team of PhD researchers, its relevance stems from a novel approach to managing biodegradable plastics within existing waste streams, validated by its selection as the first South African team to reach the finals of the Hult Prize Global Startup Competition [BusinessBeat24]. The company's core proposition is the selective breakdown of bioplastics in mixed organic waste, a process it claims can boost renewable energy generation for waste management operators without requiring costly pre-sorting [SARECO].

The founding team, led by CEO Wessel Myburgh and COO Dominique Rocher, is anchored in the academic research that underpins the technology, with both founders pursuing co-tutelage PhDs between Stellenbosch University and the University of Padova [innovus.co.za]. While the company is described as funded, no specific capital rounds, investors, or financial metrics are publicly disclosed [Tracxn, 2025].

Data Accuracy: YELLOW -- Core claims sourced from company and university channels; funding and commercial traction not independently verified.

Taxonomy Snapshot

Axis	Classification
Stage	Pre-Seed
Business Model	B2B
Industry / Vertical	Cleantech / Climatetech
Technology Type	Biotech / Life Sciences
Geography	Sub-Saharan Africa
Growth Profile	Venture Scale
Founding Team	Academic Spinout

How the Company Got Here

Urobo Biotech is a 2023 spinout from Stellenbosch University, formed to commercialize academic research on enzymatic degradation of bioplastics. The company is headquartered in Stellenbosch, South Africa, and its founding team is anchored by two PhD researchers, Wessel Myburgh and Dominique Rocher, who are pursuing co-tutelage doctorates between Stellenbosch University and the University of Padova [innovus.co.za]. Academic collaborators listed as co-founders include professors Marinda Viljoen-Bloom and Lorenzo Favaro [unipd.it].

In 2025, the team became the first from South Africa to reach the finals of the Hult Prize Global Startup Competition [BusinessBeat24] [alessandria.today, 2025]. That same year, they secured R20,000 (approximately $1,100) for a second-place finish at the Hult Prize South Africa National Showcase [timeslive.co.za, 2025]. In 2026, Urobo Biotech won the grand prize at the SWEAT Africa pitch competition, securing R100,000 in non-dilutive funding [Stellenbosch University] [sweat.africa]. The company also participated in the SARECO program in 2024 and the Hult Prize Digital Incubator in 2025 [SARECO, 2024] [Hult Prize, 2025].

Data Accuracy: YELLOW -- Company details and milestone dates are corroborated across multiple university and competition sources.

Product and Technology

Urobo Biotech's core proposition is a biological process designed to address a specific operational headache for waste management facilities. The company is developing enzymatic and microbial technologies to selectively break down bioplastics within mixed organic waste streams, aiming to convert this material into higher-value chemicals and fuels [urobobiotech.com]. The primary claim is that this process can occur without the need for costly and complex pre-sorting of waste.

The intended application is within existing anaerobic digestion or organic waste treatment facilities. By introducing their biocatalysts, Urobo Biotech asserts the technology can boost the renewable energy output, such as biogas, generated from waste that contains bioplastics [SARECO].

Data Accuracy: YELLOW -- Product claims sourced from company website and incubator profile; technical specifications and performance metrics are not publicly available.

Where the Demand Sits

The market for Urobo Biotech's solution is defined by a structural gap in waste management infrastructure. The company operates at the intersection of the global push for circular economies, the mandated phase-out of conventional plastics, and the challenge of managing end-of-life bioplastics.

According to the European Bioplastics Association, global bioplastics production capacity is projected to increase from approximately 2.4 million tonnes in 2024 to over 7.5 million tonnes by 2028 [European Bioplastics, 2024]. Over 140 countries have enacted legislation to restrict single-use plastics [UNEP, 2023]. The broader industrial enzymes market was valued at an estimated $7.1 billion in 2023 and is forecast to grow at a compound annual rate of 6.8% through 2030 [Grand View Research, 2024].

Metric	Value
Bioplastics Production 2024	2.4 million tonnes
Bioplastics Production 2028	7.5 million tonnes

Data Accuracy: YELLOW -- Market sizing is drawn from third-party industry reports for analogous sectors.

Competitive Landscape

Urobo Biotech enters a competitive field defined by broad waste management incumbents and specialized biotech startups. Large-scale waste management and recycling incumbents, such as Veolia and Suez, handle mixed waste streams but their core technologies are mechanical and thermal. Chemical recycling startups targeting conventional plastics, such as Agilyx or Loop Industries, deploy pyrolysis or depolymerization but generally require sorted, clean feedstock.

The segment most directly relevant to Urobo Biotech is the emerging field of enzymatic and microbial waste conversion. Companies like Carbios (France) have gained attention for developing enzymes to break down PET plastics, but their process is designed for purified PET streams. Urobo Biotech's claimed edge is its technology engineered to function selectively within the complex environment of an anaerobic digester or composting facility [urobobiotech.com].

Data Accuracy: YELLOW -- Competitive analysis is inferred from the broader market context.

Opportunity

The headline opportunity is to become the default enzymatic processing solution for bioplastic waste in mixed organic streams. The company's core technical claim, that its enzymes can selectively break down bioplastics without pre-sorting, directly addresses a pain point for waste facilities as bioplastic adoption increases [urobobiotech.com].

Scenario	What happens	Catalyst	Why it's plausible
Technology Licensing to Major Waste Operators	Urobo's enzymatic process is licensed to large, multinational waste management companies.	A pilot partnership with a single regional operator demonstrates a measurable increase in biogas yield.	The company's stated target customer is waste management companies [SARECO].
Vertical Integration as a Specialty Processor	Urobo establishes its own dedicated processing hubs or partners with bio-refineries.	Securing offtake agreements with chemical manufacturers for consistent supply of monomers.	The company's published approach mentions converting waste into high-value chemicals and fuels [urobobiotech.com].

Data Accuracy: YELLOW -- Opportunity framing relies on company-stated value propositions and academic research.

Sources

1. [urobobiotech.com] About Urobo Biotech | https://www.urobobiotech.com/about-urobo-biotech/
2. [SARECO] Urobo Biotech Profile | https://www.sareco.org/profile/urobo-biotech/
3. [BusinessBeat24] South Africa’s Urobo Biotech Signals New Era for African Biotech | https://businessbeat24.com/south-africas-urobo-biotech-signals-new-era-for-african-biotech/
4. [innovus.co.za] Wessel and Dominique of Urobo Biotech Addresses Global Climate Challenges | https://innovus.co.za/wessel-and-dominique-of-urobo-biotech-addresses-global-climate-challenges/
5. [Tracxn, 2025] Urobo Biotech Company Profile | https://tracxn.com/d/companies/urobo-biotech/__FXJgH9GsyT8LA342Wj1SiHDaj9ORwPColkd9eSg09E8
6. [unipd.it] Urobo Biotech among top 22 startups of the Hult Prize | https://www.unipd.it/news/clone-urobo-biotech-top-22-start-dellhult-prize
7. [alessandria.today, 2025] UROBO BIOTECH NEL GOTHA DELL’HULT PRIZE | https://alessandria.today/2025/07/28/urobo-biotech-nel-gotha-dellhult-prize-selezionata-tra-oltre-188-000-pretendenti-da-131-paesi-e-tra-le-22-migliori-start-up-studentesche/
8. [timeslive.co.za, 2025] Hult Prize SA National Showcase | https://timeslive.co.za/2025/09/10/hult-prize-sa-national-showcase/
9. [Stellenbosch University] SU biotech spin-out bags SWEAT Africa 2026 pitch prize | https://www.su.ac.za/en/news/su-biotech-spin-out-bags-sweat-africa-2026-pitch-prize
10. [sweat.africa] SWEAT Africa 2026 | https://sweat.africa/
11. [SARECO, 2024] SARECO 2024 Program | https://www.sareco.org/
12. [Hult Prize, 2025] Digital Incubator Introductions: Urobo Biotech | https://www.youtube.com/shorts/NFxobkGhv-o
13. [Stellenbosch University, 2024] Research reveals environmental and commercial benefits to tackling bioplastics disposal dilemma | https://www0.sun.ac.za/researchforimpact/2024/05/07/research-reveals-environmental-and-commercial-benefits-to-tackling-bioplastics-disposal-dilemma/
14. [European Bioplastics, 2024] Bioplastics market data 2024 | https://www.european-bioplastics.org/market/
15. [UNEP, 2023] Global plastics outlook | https://www.unep.org/resources/global-plastics-outlook
16. [Grand View Research, 2024] Industrial Enzymes Market Size Report, 2024-2030 | https://www.grandviewresearch.com/industry-analysis/industrial-enzymes-market